brazzo / iStockphoto.com
SPCs and trade secrets are just two issues set to be discussed at C5’s 11th Pharma & Biotech Patent Litigation, on February 26 and 27 in Amsterdam. LSIPR reports.
We are entering a new era for European patent litigation which will have resounding effects on the life sciences industry.
Attend C5’s 11th Pharma & Biotech Patent Litigation and receive vital updates and in-depth analysis on how to enhance litigation strategies and achieve favourable results.
Key highlights for the 2019 event include discussions on:
- The impact of Brexit on the Unitary Patent Court
- The Trade Secret Directive’s effect on patent rights
- The repercussions of recent Court of Justice of the European Union’s supplementary protection certificate (SPC) rulings
- Digital concerns for the quality of patents
- Functional patent claims and related burden of proof analyses
This conference will provide you with inside knowledge about cross-jurisdictional patent litigation from an elite speaker line-up consisting of more than 25 speakers from the pharmaceutical and biotechnology patent sphere.
“This conference will provide you with inside knowledge about cross-jurisdictional patent litigation.”
Our prior delegates say it best:
“The combination of networking opportunities with people from various backgrounds. Concise overview over the most relevant topics.” Andreas Geissler, Leukocare.
“Good networking opportunities with in-house counsel and leading IP law firms. Hot topics, great speakers and convenient number of attendants.” Anna Lopez Lozano, Esteve Química.
“Important subject matters to discuss presented by renowned specialists. An important conference to attend.” Manuel Duraes Rocha, Abreu Advogados.
Get 10% off with code P10-630-LSPR19. Call +44 (0)20 7878 6888 or register online at www.c5-online.com/PPLitigation